Daiwa upgrades Honeywell stock rating on aerospace spin-off

Daiwa upgraded Honeywell International to Outperform and raised its price target to $255 from $240, arguing the stock looks undervalued with substantial upside. The company completed the Aerospace spin-off, renamed itself Honeywell Technologies, and executed a 1-for-2 reverse split; Daiwa set EPS estimates for Honeywell Technologies at $8.20 (2026), $9.50 (2027), and $10.75 (2028). Management targets 4%–6% revenue CAGR, expects outperformance by expanding the 60% of sales installed-base (data centers, LNG, grid, life sciences, healthcare, hospitality), and aims to lift software/services penetration from 40% to 45% via the Forge platform.

Analysis

The near-term setup is more about multiple mechanics than fundamentals: the separation removes the conglomerate discount only if the market believes the remaining business can sustain mid-single-digit growth without aerospace masking cyclicality. That favors a re-rating in the 1-3 month window around the next print, but only if management can show software/service mix expansion and stable margins; otherwise the market will treat the move as financial engineering and compress the stock back toward a plain-vanilla industrial multiple.

Second-order winners are the automation/software comps, not the obvious aerospace peers. If Honeywell’s installed-base and Forge narrative sticks, it pressures EMR, JCI, ETN, and even parts of ABB to defend valuation premiums on recurring revenue and service attach. On the flip side, the new aerospace vehicle could pull some passive and factor interest away from names like RTX and GE, but that only matters if the separated asset is large enough to become a true indexable aerospace compounder.

The main risk is that the split surfaces stranded cost and slows the parent’s reported growth right when end markets are already crowded trade areas. The stock is vulnerable if July 23 commentary shows that 2026 EPS estimates are too aggressive, or if data center/LNG exposure proves more cyclical than advertised. The contrarian view is that the market may be overpricing the purity benefit: a cleaner structure does not automatically create faster organic growth, and reverse splits often help optics more than intrinsic value.

Key Decisions for Investors

• Buy HON on any post-upgrade pullback into the July 23 earnings event; target a 6-12 month re-rating if management confirms 2026 guidance and margin expansion. Invalidated if organic growth slips below the low end of the stated 4%-6% range or software/services mix stalls under 40s.
• Pair trade: long HON / short EMR or JCI for the next 1-3 months to express the better recurring-revenue mix and installed-base monetization. The trade works if HON outperforms on guide quality; cover if industrial automation order trends weaken or HON fails to expand forward EPS.
• If HONAV is liquid and separately listed, consider a relative-value long HONAV vs short HON position around the first post-separation trading window. Thesis: aerospace may get a higher pure-play multiple, but execution/stranded-cost risk is higher; reverse if aftermarket demand softens or defense/airline cycle data rolls over.
• Set a watch level on HON: if the stock rerates more than ~8%-10% before results, fade part of the move rather than chase it. The catalyst is confirmatory commentary, not the headline spin mechanics.